Moving from Big Pharma to Biotech – Insights from Two Biotech CEOs
According to John LaMattina in Forbes last year, more and more senior scientific executives are…
According to John LaMattina in Forbes last year, more and more senior scientific executives are…
ViiV Healthcare has just started a clinical trial to test if its two-drug regimen for…
Update (24/10/2017): Shingrix has been approved by the FDA and will cost $280 (€238) for the…
May 5, 2017, saw the first FDA approval for an amyotrophic lateral sclerosis (ALS) drug…
A British-American collaboration's once-daily triple therapy inhaler has been approved for use by appropriate COPD…
This infographic gathers 10 of the best HIV treatments in Europe's pipeline that will help…
After Sanofi recruited Exscientia in a €250M deal last May, GSK has taken an interest in…
The UK-based VC Medicxi has raised a massive $300M (€268M) fund backed by Novartis and…
Immunocore has singled out a new lead candidate in its immuno-oncology discovery program with GSK,…
GSK has punched a hole in the glass ceiling with its appointment of a new…
Blockbuster drugs are raking in billions each year in sales. Let's have a look at the top…
We've compiled a list of some of the latest advances of biotech in the field…